Encainide
Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.[1]
![]() | |
Clinical data | |
---|---|
Trade names | Enkaid |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a605040 |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H28N2O2 |
Molar mass | 352.478 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Synthesis
gollark: What? I wasn't using any pronouns referring to you.
gollark: If it's really a problem I can have ubq say "in the linear algebra sense" or something but nobody else seems to have had issues. Unless they have but didn't say. Oh well.
gollark: Oh, right, I understand what you mean now probably, yes.
gollark: Yeeees?
gollark: Gnreetings, gnobody.
See also
References
- Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. (March 1991). "Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial". The New England Journal of Medicine. 324 (12): 781–8. doi:10.1056/NEJM199103213241201. PMID 1900101.
- DE 2210154, Dykstra SJ, Minelli JL, issued 1972
- US 3931195, Dykstra SJ, Minelli JL, issued 1976
- Dykstra SJ, Minielli JL, Lawson JE, Ferguson HC, Dungan KW (September 1973). "Lysergic acid and quinidine analogs. 2-(o-Acylaminophenethyl)piperidines". Journal of Medicinal Chemistry. 16 (9): 1015–20. doi:10.1021/jm00267a012. PMID 4745503.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.